Sandhya Narise
About Sandhya Narise
Data last updated:
Sandhya Narise is a Director at Sri Sampath Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Sri Sampath Pharmaceuticals Private Limited reported revenue of ₹1.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Sampath Pharmaceuticals Private Limited U24230TG2021PTC156882 | Director | 11 Nov 2021 | 2021 | ₹1.45 Cr (FY 2025) | Active |
Board colleagues of Sandhya Narise
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramana Murthy Esapari | 09396185 | Sri Sampath Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandhya Narise
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandhya Narise
Sandhya Narise currently holds 1 directorship: Sri Sampath Pharmaceuticals Private Limited (Director, since 11 Nov 2021, revenue ₹1.45 Cr (FY 2025)).
Sandhya Narise was first appointed on 11 Nov 2021 as Director at Sri Sampath Pharmaceuticals Private Limited.
The current boards of Sandhya Narise's companies include Ramana Murthy Esapari (Sri Sampath Pharmaceuticals Private Limited).